These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2102791)

  • 1. Monoclonal antibody-based plasma assays for fibrin(ogen) and derivatives, and their clinical relevance.
    Kroneman H; Nieuwenhuizen W; Knot EA
    Blood Coagul Fibrinolysis; 1990; 1(1):91-111. PubMed ID: 2102791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies.
    Nieuwenhuizen W
    Blut; 1988 Nov; 57(5):285-91. PubMed ID: 3058234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between plasma levels of fibrin(ogen) derivatives as quantified by different assays based on monoclonal antibodies.
    Kroneman H; Nieuwenhuizen W; Knot EA; Van Bergen PF; De Maat MP
    Thromb Res; 1991 Feb; 61(4):441-52. PubMed ID: 1953861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Am J Clin Pathol; 1986 Mar; 85(3):360-4. PubMed ID: 2875646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
    Greenberg CS; Devine DV; McCrae KM
    Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.
    Bini A; Fenoglio JJ; Mesa-Tejada R; Kudryk B; Kaplan KL
    Arteriosclerosis; 1989; 9(1):109-21. PubMed ID: 2643421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
    Amiral J; Grosley M; Mimilla F; Plassart V; Chambrette B
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):447-52. PubMed ID: 1723302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
    Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
    Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease.
    vanDeWater L; Carr JM; Aronson D; McDonagh J
    Blood; 1986 May; 67(5):1468-73. PubMed ID: 2938648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique.
    Connaghan DG; Francis CW; Lane DA; Marder VJ
    Blood; 1985 Mar; 65(3):589-97. PubMed ID: 3971042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that fibrin(ogen) degradation products (FDP) are adequately quantified in citrated plasma defibrinated at low pH.
    Godal HC; Hamborg T
    Scand J Haematol; 1984 Jan; 32(1):46-8. PubMed ID: 6695150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of disseminated intravascular coagulation: the value of soluble fibrin, D-dimers and fibrin(ogen) split products].
    Wieding JU; Eisinger G; Köstering H
    Klin Wochenschr; 1989 Aug; 67(15):764-73. PubMed ID: 2770191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.
    Whitaker AN; Elms MJ; Masci PP; Bundesen PG; Rylatt DB; Webber AJ; Bunce IH
    J Clin Pathol; 1984 Aug; 37(8):882-7. PubMed ID: 6206097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems.
    Hunt FA; Rylatt DB; Hart RA; Bundesen PG
    Br J Haematol; 1985 Aug; 60(4):715-22. PubMed ID: 3896298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
    Horan JT; Francis CW
    Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Value of Assays of Fibrin Degradation Products, and Their Use in the Netherlands.
    Nieuwenhuizen W
    EJIFCC; 2000 Sep; 12(3):82. PubMed ID: 30532683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays.
    de Maat MP; Nieuwenhuizen W; Knot EA; van Buuren HR; Swart GR
    Thromb Res; 1995 May; 78(4):353-62. PubMed ID: 7631315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.